Susan foden

Biography

 Dr. Susan Elizabeth (Sue) Foden, Ph.D. has served as Non-Executive Independent Director of Bergenbio ASA since September 8, 2011. She was also Chairman of the Board of the Company until February 2016. She holds a number of Non-Executive Directorships with both public and private companies and public funding bodies in the biotech and healthcare field, including Vectura plc., Source Bioscience plc., Rainbow Seed Fund, Cascade Ltd and Oxford Ancestors Ltd. Previously, she held positions in venture capital and United Kingdom biotech companies. From 2000 to 2003, she was an Investor Director with the London-based VC firm Merlin Biosciences Limited, and was Chief Executive Officer of the technology transfer company Cancer Research Campaign Technology. She studied biochemistry at the University of Oxford from where she obtained a Master of Arts degree and Doctorate in Philosphy. She serves at British Technology Group Plc (board member), Vectura Group Plc (board member), Evgen Plc (board member), Oxford Ancestors Ltd (board member) Source Bioscience plc (board member), Rainbow Seed Fund (board member) and The Cell and Gene Therapy Catapult (board member). Previously, she was employed at Rainbow Seed Fund (board member), the Cascade Fund (board member), Cizzle Biotech Ltd (chairman), Rainbow Seed Fund Ltd and Source BioScience plc (board member).

Research Interest

 Pharmaceutical